Related Experiment Video
Updated: Sep 7, 2025

06:16
mirMachine: A One-Stop Shop for Plant miRNA Annotation
Published on: May 1, 2021
2.6K
PUMILIO competes with AUF1 to control DICER1 RNA levels and miRNA processing.
Swetha Rajasekaran1,2, Eshan Khan1,2, Samuel R Ching3
1Department of Cancer Biology and Genetics, The Ohio State University, 460 West 12th Avenue, Columbus, OH 43210, USA.
Nucleic Acids Research
|June 23, 2022
Summary
DICER1 syndrome, a cancer predisposition disorder, arises from mutations affecting DICER1 function. A specific allele disrupts PUMILIO binding, leading to DICER1 mRNA degradation and altered miRNA networks.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- DICER1 syndrome is a hereditary cancer predisposition disorder.
- Mutations in DICER1 disrupt microRNA (miRNA) processing, impacting cellular homeostasis and tumor development.
- Understanding these mutations offers insights into novel regulatory mechanisms.
Purpose of the Study:
- To analyze a pathogenic DICER1 syndrome allele located in the DICER1 3' untranslated region (3'UTR).
- To investigate the molecular consequences of this specific allele on DICER1 mRNA regulation.
- To elucidate the role of post-transcriptional regulation in DICER1 levels.
Main Methods:
- Analysis of the rs1252940486 DICER1 allele.
- Investigating the interaction between the DICER1 3'UTR and RNA binding proteins.
- Assessing DICER1 mRNA and protein levels.
- Evaluating miRNA network alterations.
Main Results:
- The rs1252940486 allele abolishes the interaction between the DICER1 3'UTR and the PUMILIO RNA binding protein.
- This disruption leads to AUF1-mediated degradation of DICER1 mRNA.
- A significant decrease in DICER1 mRNA and protein levels was observed.
- Widespread reprogramming of miRNA networks occurred due to diminished DICER1 levels.
Conclusions:
- The rs1252940486 DICER1 allele significantly impacts DICER1 mRNA stability through disrupted PUMILIO binding and enhanced AUF1 degradation.
- This single mutation profoundly affects miRNA processing and cellular regulation, contributing to DICER1 syndrome.
- The study highlights critical post-transcriptional regulatory events controlling DICER1 levels and their role in disease pathogenesis.
Related Concept Videos
piRNA - Piwi-interacting RNAs
7.0K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.0K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

